Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Mar 17, 2015 · 10-K · 76 days after period end · 0001144204-15-016579
| Metric | Q4 2014 | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | $872.00K | $0.00 | $322.00K | $0.00 |
| Net Income | -$42.69M | -$16.89M | -$30.52M | -$12.58M |
| EPS Diluted | -$0.64 | — |
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2014 · filed Mar 17, 2015 · 76 d after period end
